本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Akari Therapeutics PLC

11.30
+0.42003.86%
盤後12.621.32+11.68%19:57 EDT
成交量:13.52萬
成交額:149.95萬
市值:2,200.11萬
市盈率:-0.71
高:11.50
開:10.51
低:10.51
收:10.88
52周最高:49.60
52周最低:3.02
股本:194.70萬
流通股本:69.45萬
量比:1.13
換手率:19.46%
股息:- -
股息率:- -
每股收益(TTM):-15.9015
每股收益(LYR):-20.5537
淨資產收益率:-140.09%
總資產收益率:-19.10%
市淨率:1.18
市盈率(LYR):-0.55

資料載入中...

2020/11/16

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/08/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/07/24

SEC問詢函

CORRESP [Cover] - Correspondence
2020/07/17

招股説明書

F-1 - Registration statement for certain foreign private issuers
2020/07/02

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/04/15

SEC問詢函

CORRESP [Cover] - Correspondence
2020/03/31

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/30

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/03/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/20

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/23

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/02

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/24

SEC問詢函

[Cover]Correspondence
2019/10/15

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]